GI Dynamics Announces Agreement With CMS Medical for Distribution of EndoBarrier® Therapy in Brazil
3/6/2013 10:49:22 AM
More...
|
New Implantable Device Helps Diabetics Control Blood Sugar, Lose Weight, GI Dynamics Reveals
2/7/2013 8:20:37 AM
More...
|
GI Dynamics Initiates U.S. Pivotal Clinical Trial of EndoBarrier®
1/15/2013 9:59:27 AM
More...
|
GI Dynamics Settles Patent Litigation With W. L. Gore & Associates, Inc.
1/10/2013 7:06:28 AM
More...
|
GI Dynamics Inks Research Deals With Medtronic, Inc. (MDT), GlaxoSmithKline (GSK)
1/9/2013 10:38:14 AM
More...
|
GI Dynamics Receives FDA Approval to Commence Pivotal Clinical Trial of EndoBarrier®
10/30/2012 6:26:10 AM
More...
|
GI Dynamics Announces New Insights into EndoBarrier™ Therapy’s Influence on Key Hormones Affecting Satiety and Blood Sugar Control
10/22/2012 9:51:05 AM
More...
|
GI Dynamics Announces First Clinical Study to Demonstrate Improvement in Weight Loss and Co-morbid Conditions Following EndoBarrier™ Re-implantation
10/22/2012 9:47:33 AM
More...
|
GI Dynamics Release: St. Vincent's Clinic and Macquarie University in Sydney Incorporate EndoBarrier® Therapy Into Type 2 Diabetes and Obesity Treatment Option
9/24/2012 9:59:04 AM
More...
|
GI Dynamics Gets FDA Nod for Pivotal Obesity Trial
8/23/2012 9:10:50 AM
More...
|
|